EVOQUE Adverse Events: FDA MAUDE Data

Edwards Lifesciences LLC · Transcatheter Tricuspid Valve Replacement · First cleared Feb 2024

Total Reports

665

Reports (30d)

24

Active Signals

1

Open Recalls

1

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Permanent Pacemaker on POD 0

right, days procedure, day procedure, vein permanent

55

reports

2

AV Block Post-Implant from Oversizing

wire, involving, post, ttvr, valve replacement

46

reports

3

Patient Expired 30 Days Post-Implant

patient expired, pod information, surgery intervention, tricuspid valve, expired pod

31

reports

4

Unplanned Cardiac Surgery 12 Days Post

surgery intervention, cardiac surgery, days procedure, intervention unplanned, unplanned days

20

reports

5

Permanent Pacemaker on POD 2

vein permanent

17

reports

6

Permanent Pacemaker on POD 1

vein permanent

14

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Active safety signals

Disproportionate reportinghigh

FDA recalls for this device

Class II

Mar 27, 2026 · Open, Classified

Labeling update to provide warning if functionality of the valve replacement delivery system is compromised.

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 1 active signal detected right now.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.